Oxymetholone
Also known as: Anadrol, A50
Status
No approved product. FDA-approved as Anadrol-50 (NDA 016848) for certain anemias, with a boxed warning for hepatic effects; Drugs@FDA lists the product as discontinued (retrieved 25 October 2026), so no marketed FDA-approved product was found. Schedule III controlled substance.
What it is
A potent oral androgen once FDA-approved for certain anemias (as Anadrol-50, now listed as discontinued), with a boxed warning to match.
What published research measured
Approved for anemias caused by deficient red cell production, so unlike most of this category it has a genuine label and a documented safety profile — which is precisely why the profile is worth reading. The label carries a boxed warning covering peliosis hepatis, liver cell tumors and blood lipid changes, noting that these can be life-threatening and are often discovered late because they may be silent until a complication occurs.
Caution
FDA-approved as Anadrol-50 (NDA 016848) for certain anemias, with a boxed warning for hepatic effects; Drugs@FDA lists the product as discontinued (retrieved 25 October 2026), so no marketed FDA-approved product was found. Schedule III controlled substance.
Source
Not tied to a single designated source; see the published research on this molecule
Sources
No linked primary source is on file for this entry yet.
Educational use only, never medical advice. No doses.